F2 and autoimmune polyendocrinopathy: However, during the last international congress on aPL antibodies, the major experts defined the role of other so-called “non criteria” antibodies, contributing to assess the risk of thrombosis or the identification of potential seronegative APS, such as the anti-prothrombin/phosphatidylserine antibodies (aPS/PT) [3].